Iwakuni, Japan

Kazuhiko Itoh


Average Co-Inventor Count = 7.5

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Hino, JP (1979)
  • Iwakuni, JP (1994)

Company Filing History:


Years Active: 1979-1994

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kazuhiko Itoh: Innovator in Pharmaceutical Chemistry

Introduction

Kazuhiko Itoh is a prominent inventor based in Iwakuni, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 2 patents, his work has garnered attention for its potential impact on medical treatments.

Latest Patents

Kazuhiko Itoh's latest patents include innovative formulations such as the human tissue plasminogen activator and human plasminogen activator inhibitor. Additionally, he has developed benzodiazepine derivatives and pharmaceutical compositions containing novel 4H-pyrrolo[1,2-a][1,4]benzodiazepine derivatives. These compounds are designed to have useful anti-anxiety, sedative, anti-convulsant, muscle relaxant, and hypnotic properties, while maintaining low toxicity levels.

Career Highlights

Throughout his career, Kazuhiko Itoh has been associated with Teijin Limited, where he has played a crucial role in advancing pharmaceutical research. His innovative approach to drug development has positioned him as a key figure in the industry.

Collaborations

Kazuhiko has collaborated with notable colleagues, including Takeshi Hara and Yasutaka Kayama. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Kazuhiko Itoh's contributions to pharmaceutical chemistry exemplify the importance of innovation in developing new therapeutic agents. His work continues to influence the field and holds promise for future advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…